Does the media prefer RCEL or AVR?

In the previous week, Avita Medical had 4 more articles in the media than Anteris Technologies Global. MarketBeat recorded 8 mentions for Avita Medical and 4 mentions for Anteris Technologies Global. Avita Medical's average media sentiment score of 0.49 beat Anteris Technologies Global's score of 0.23 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, RCEL or INMD?

InMode has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $71.61M 4.34 -$48.59M -$1.44 N/A InMode $370.49M 2.31 $93.83M $1.23 12.13

Is RCEL or INMD more profitable?

InMode has a net margin of 20.69% compared to Avita Medical's net margin of -56.96%. InMode's return on equity of 11.99% beat Avita Medical's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -56.96% N/A -78.53% InMode 20.69% 11.99% 10.60%

Does the media favor RCEL or INMD?

In the previous week, Avita Medical had 6 more articles in the media than InMode. MarketBeat recorded 8 mentions for Avita Medical and 2 mentions for InMode. InMode's average media sentiment score of 0.51 beat Avita Medical's score of 0.49 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, RCEL or SIBN?

SiBone has higher revenue and earnings than Avita Medical. SiBone is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $71.61M 4.34 -$48.59M -$1.44 N/A SiBone $200.93M 4.30 -$18.90M -$0.34 N/A

Is RCEL or SIBN more profitable?

SiBone has a net margin of -6.85% compared to Avita Medical's net margin of -56.96%. Avita Medical's return on equity of 0.00% beat SiBone's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -56.96% N/A -78.53% SiBone -6.85% -8.23% -6.07%

Does the media prefer RCEL or SIBN?

In the previous week, Avita Medical had 3 more articles in the media than SiBone. MarketBeat recorded 8 mentions for Avita Medical and 5 mentions for SiBone. Avita Medical's average media sentiment score of 0.49 beat SiBone's score of 0.33 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SiBone 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CBLL or RCEL?

In the previous week, CeriBell had 8 more articles in the media than Avita Medical. MarketBeat recorded 16 mentions for CeriBell and 8 mentions for Avita Medical. CeriBell's average media sentiment score of 0.61 beat Avita Medical's score of 0.49 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer RCEL or VREX?

In the previous week, Avita Medical and Avita Medical both had 8 articles in the media. Varex Imaging's average media sentiment score of 0.97 beat Avita Medical's score of 0.49 indicating that Varex Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Varex Imaging 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avita Medical (RCEL) Competitors

$10.09 -0.25 (-2.42%)

Closing price 04:00 PM Eastern

Extended Trading

$10.07 -0.02 (-0.15%)

As of 05:57 PM Eastern

Compare

RCEL vs. AVR, INMD, SIBN, CBLL, and VREX

Should you buy Avita Medical stock or one of its competitors? Avita Medical's main competitors and comparable companies include Anteris Technologies Global (AVR), InMode (INMD), SiBone (SIBN), CeriBell (CBLL), and Varex Imaging (VREX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Avita Medical compare to Anteris Technologies Global?

Avita Medical (NASDAQ:RCEL) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

Avita Medical has higher revenue and earnings than Anteris Technologies Global. Avita Medical is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.34	-$48.59M	-$1.44	N/A
Anteris Technologies Global	$1.91M	471.99	-$94.14M	-$1.95	N/A

27.7% of Avita Medical shares are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Avita Medical currently has a consensus price target of $10.20, indicating a potential upside of 1.09%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 72.97%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.78, indicating that its share price is 78% more volatile than the broader market.

In the previous week, Avita Medical had 4 more articles in the media than Anteris Technologies Global. MarketBeat recorded 8 mentions for Avita Medical and 4 mentions for Anteris Technologies Global. Avita Medical's average media sentiment score of 0.49 beat Anteris Technologies Global's score of 0.23 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical has a net margin of -56.96% compared to Anteris Technologies Global's net margin of -4,619.27%. Avita Medical's return on equity of 0.00% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%

Summary

Avita Medical beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Avita Medical compare to InMode?

Avita Medical (NASDAQ:RCEL) and InMode (NASDAQ:INMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, InMode has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InMode has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.34	-$48.59M	-$1.44	N/A
InMode	$370.49M	2.31	$93.83M	$1.23	12.13

In the previous week, Avita Medical had 6 more articles in the media than InMode. MarketBeat recorded 8 mentions for Avita Medical and 2 mentions for InMode. InMode's average media sentiment score of 0.51 beat Avita Medical's score of 0.49 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical presently has a consensus target price of $10.20, indicating a potential upside of 1.09%. InMode has a consensus target price of $16.00, indicating a potential upside of 7.24%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has a net margin of 20.69% compared to Avita Medical's net margin of -56.96%. InMode's return on equity of 11.99% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
InMode	20.69%	11.99%	10.60%

Summary

InMode beats Avita Medical on 12 of the 16 factors compared between the two stocks.

How does Avita Medical compare to SiBone?

Avita Medical (NASDAQ:RCEL) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 3 more articles in the media than SiBone. MarketBeat recorded 8 mentions for Avita Medical and 5 mentions for SiBone. Avita Medical's average media sentiment score of 0.49 beat SiBone's score of 0.33 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SiBone	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, SiBone has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market.

SiBone has a net margin of -6.85% compared to Avita Medical's net margin of -56.96%. Avita Medical's return on equity of 0.00% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
SiBone	-6.85%	-8.23%	-6.07%

Avita Medical currently has a consensus price target of $10.20, indicating a potential upside of 1.09%. SiBone has a consensus price target of $24.17, indicating a potential upside of 24.06%. Given SiBone's stronger consensus rating and higher possible upside, analysts plainly believe SiBone is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

SiBone has higher revenue and earnings than Avita Medical. SiBone is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.34	-$48.59M	-$1.44	N/A
SiBone	$200.93M	4.30	-$18.90M	-$0.34	N/A

Summary

SiBone beats Avita Medical on 10 of the 16 factors compared between the two stocks.

How does Avita Medical compare to CeriBell?

CeriBell (NASDAQ:CBLL) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Avita Medical has a net margin of -56.96% compared to CeriBell's net margin of -64.73%. Avita Medical's return on equity of 0.00% beat CeriBell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-64.73%	-44.85%	-35.69%
Avita Medical	-56.96%	N/A	-78.53%

CeriBell has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market.

CeriBell presently has a consensus price target of $22.40, indicating a potential downside of 7.86%. Avita Medical has a consensus price target of $10.20, indicating a potential upside of 1.09%. Given Avita Medical's higher probable upside, analysts plainly believe Avita Medical is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Avita Medical has lower revenue, but higher earnings than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	10.48	-$53.41M	-$1.76	N/A
Avita Medical	$71.61M	4.34	-$48.59M	-$1.44	N/A

In the previous week, CeriBell had 8 more articles in the media than Avita Medical. MarketBeat recorded 16 mentions for CeriBell and 8 mentions for Avita Medical. CeriBell's average media sentiment score of 0.61 beat Avita Medical's score of 0.49 indicating that CeriBell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

27.7% of Avita Medical shares are owned by institutional investors. 17.7% of CeriBell shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Avita Medical beats CeriBell on 9 of the 17 factors compared between the two stocks.

How does Avita Medical compare to Varex Imaging?

Avita Medical (NASDAQ:RCEL) and Varex Imaging (NASDAQ:VREX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Varex Imaging has a net margin of 2.55% compared to Avita Medical's net margin of -56.96%. Varex Imaging's return on equity of 9.19% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
Varex Imaging	2.55%	9.19%	4.13%

27.7% of Avita Medical shares are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 4.6% of Varex Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Avita Medical has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Avita Medical currently has a consensus target price of $10.20, indicating a potential upside of 1.09%. Varex Imaging has a consensus target price of $16.88, indicating a potential downside of 8.73%. Given Avita Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Avita Medical is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Varex Imaging	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Avita Medical has higher earnings, but lower revenue than Varex Imaging. Avita Medical is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.34	-$48.59M	-$1.44	N/A
Varex Imaging	$844.60M	0.92	-$70.30M	$0.52	35.56

In the previous week, Avita Medical and Avita Medical both had 8 articles in the media. Varex Imaging's average media sentiment score of 0.97 beat Avita Medical's score of 0.49 indicating that Varex Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Varex Imaging	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Varex Imaging beats Avita Medical on 8 of the 15 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$318.23M	$5.96B	$7.37B	$12.86B
Dividend Yield	N/A	1.74%	2.53%	10.69%
P/E Ratio	-7.01	21.39	209.18	20.84
Price / Sales	4.34	65.73	621.61	93.92
Price / Cash	N/A	33.51	78.13	53.57
Price / Book	-11.21	5.90	13.07	6.15
Net Income	-$48.59M	$148.28M	$3.46B	$347.39M
7 Day Performance	25.97%	0.55%	1.43%	-0.64%
1 Month Performance	96.30%	5.75%	4.58%	2.12%
1 Year Performance	115.14%	9.08%	27.60%	20.16%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	1.7386 of 5 stars	$10.09 -2.4%	$10.20 +1.1%	+112.3%	$318.23M	$71.61M	N/A	130	News Coverage Analyst Forecast
AVR Anteris Technologies Global	2.8472 of 5 stars	$9.18 +2.5%	$16.00 +74.3%	+168.6%	$893.97M	$1.91M	N/A	138
INMD InMode	1.7663 of 5 stars	$15.23 +0.2%	$16.00 +5.1%	+6.1%	$875.71M	$370.49M	12.39	480
SIBN SiBone	2.9037 of 5 stars	$18.94 +0.5%	$24.17 +27.6%	+28.5%	$839.10M	$200.93M	N/A	350	Positive News
CBLL CeriBell	1.2721 of 5 stars	$20.67 +7.1%	$22.00 +6.5%	+111.1%	$784.47M	$95.07M	N/A	N/A	News Coverage Analyst Forecast Insider Trade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. AVR, INMD, SIBN, CBLL, and VREX

How does Avita Medical compare to Anteris Technologies Global?

Summary

How does Avita Medical compare to InMode?

Summary

How does Avita Medical compare to SiBone?

Summary

How does Avita Medical compare to CeriBell?

Summary

How does Avita Medical compare to Varex Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. AVR, INMD, SIBN, CBLL, and VREX

How does Avita Medical compare to Anteris Technologies Global?

Which has stronger valuation & earnings, RCEL or AVR?

Do institutionals & insiders believe in RCEL or AVR?

Do analysts recommend RCEL or AVR?

Which has more risk and volatility, RCEL or AVR?

Does the media prefer RCEL or AVR?

Is RCEL or AVR more profitable?

Summary

How does Avita Medical compare to InMode?

Which has more risk and volatility, RCEL or INMD?

Do insiders & institutionals believe in RCEL or INMD?

Which has preferable earnings & valuation, RCEL or INMD?

Does the media favor RCEL or INMD?

Do analysts prefer RCEL or INMD?

Is RCEL or INMD more profitable?

Summary

How does Avita Medical compare to SiBone?

Do insiders & institutionals have more ownership in RCEL or SIBN?

Does the media prefer RCEL or SIBN?

Which has more risk and volatility, RCEL or SIBN?

Is RCEL or SIBN more profitable?

Do analysts prefer RCEL or SIBN?

Which has stronger earnings & valuation, RCEL or SIBN?

Summary

How does Avita Medical compare to CeriBell?

Is CBLL or RCEL more profitable?

Which has more volatility & risk, CBLL or RCEL?

Do analysts rate CBLL or RCEL?

Which has better earnings and valuation, CBLL or RCEL?

Does the media refer more to CBLL or RCEL?

Do insiders & institutionals believe in CBLL or RCEL?

Summary

How does Avita Medical compare to Varex Imaging?

Is RCEL or VREX more profitable?

Do institutionals and insiders believe in RCEL or VREX?

Which has more risk & volatility, RCEL or VREX?

Do analysts recommend RCEL or VREX?

Which has preferable valuation & earnings, RCEL or VREX?

Does the media prefer RCEL or VREX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools